...
首页> 外文期刊>Microvascular Research: An International Journal >Capillary blood cell velocity in finger nailfold: effect of enalapril and mibefradil in patients with mild to moderate hypertension.
【24h】

Capillary blood cell velocity in finger nailfold: effect of enalapril and mibefradil in patients with mild to moderate hypertension.

机译:手指皱纹处的毛细血管血流速度:依那普利和咪贝拉地尔在轻度至中度高血压患者中的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Outpatients with essential hypertension were randomized to receive antihypertensive treatment with either mibefradil or enalapril. Ambulatory blood pressure measurement (ABPM) and video capillary microscopy of the finger nailfold were performed at baseline and after 12 weeks of treatment. In the enalapril group (n = 21) baseline ABP was 156 +/- 12/100 +/- 9 mm Hg and decreased to 140 +/- 17/89 +/- 10 mm Hg after 12 weeks. In the mibefradil group (n = 22) mean 24-h ABP decreased from 159 +/- 14/102 +/- 7 to 140 +/- 10/89 +/- 7 mm Hg. Capillary blood cell velocity (CBV) without treatment was 0.90 +/- 0.58 mm/s (mean +/- SD) and 0.83 +/- 0.46 mm/s at rest and 0.30 +/- 0.22 and 0.21 +/- 0.20 mm/s immediately after local finger cooling in the mibefradil and the enalapril group, respectively. In the Enalapril group CBV at week 12 was 0.99 +/- 0. 60 mm/s (n.s.) at rest and 0.40 +/- 0.28 mm/s immediately after local cooling (P = 0.005 compared to 0.21 +/- 0.20 mm/s without treatment). Twelve weeks after initiation of treatment CBV was 0.76 +/- 0.48 mm/s (n.s.) at rest and 0.31 +/- 0.28 mm/s (n.s.) immediately after local cooling in the mibefradil group. Finger nailfold CBV immediately after local finger cooling was increased by enalapril compared to baseline. The T-channel-inhibiting calcium antagonist mibefradil did not change CBV in finger nailfold capillaries. Copyright 1999 Academic Press.
机译:门诊患有原发性高血压的患者被随机分配接受米贝拉地尔或依那普利的降压治疗。在治疗的基线和治疗12周后进行手指血压的动态血压测量(ABPM)和视频毛细管显微镜检查。在依那普利组(n = 21)中,基线ABP为156 +/- 12/100 +/- 9 mm Hg,并在12周后降至140 +/- 17/89 +/- 10 mm Hg。在米贝地尔组(n = 22)中,平均24小时ABP从159 +/- 14/102 +/- 7降至140 +/- 10/89 +/- 7 mm Hg。未经治疗的毛细血管速度(CBV)为0.90 +/- 0.58 mm / s(平均+/- SD)和静止时为0.83 +/- 0.46 mm / s,以及0.30 +/- 0.22和0.21 +/- 0.20 mm /分别在米贝拉地尔和依那普利组中,在局部手指冷却后立即开始治疗。在Enalapril组中,第12周的CBV为0.99 +/- 0.静止时为60 mm / s(ns),局部冷却后立即为0.40 +/- 0.28 mm / s(P = 0.005,而0.21 +/- 0.20 mm / s,无需治疗)。在开始治疗后的十二周,米贝拉地尔组的静息CBV为静止时0.76 +/- 0.48 mm / s(n.s。)和刚冷却后的0.31 +/- 0.28 mm / s(n.s。)。与基线相比,依那普利可在局部手指冷却后立即使手指指甲CBV增加。抑制T通道的钙拮抗剂米贝拉地尔不会改变指甲毛细血管中的CBV。版权所有1999 Academic Press。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号